A Sampling of Highlights from the Literature

出处
期刊:Cancer immunology research [American Association for Cancer Research]
卷期号:11 (1): 1-1
标识
DOI:10.1158/2326-6066.cir-11-1-wwr
摘要

Myocarditis is the most lethal ICI-associated adverse event (from OpenStax Anatomy and Physiology via Wikimedia Commons)Myocarditis is a rare, often fatal, and poorly mechanistically understood adverse event associated with immune checkpoint inhibitor (ICI) therapy. Axelrod et al. find that in a mouse model of ICI-associated myocarditis—Pdcd1–/–Ctla4+/–mice—CD8+ T cells are necessary for fatal myocarditis to develop. The cardiac-infiltrating CD8+ T cells are highly clonal, with the T-cell receptors (TCR) from three clones recognizing MHC class I–presented α-myosin peptides. The clinical relevance of the data is supported by the detection of α-myosin–specific MHC class I–restricted TCRs in cardiac and skeletal muscle of patients with ICI-associated myocarditis.Axelrod ML, …, Balko JM. Nature 2022 November 16;611:818–26.Research is identifying new ways to enhance the antitumor activity of CAR T cells (from Alex Ritter, Jennifer Lippincott Schwartz, and Gillian Griffiths via NIH Flickr)Many research groups are working to expand the therapeutic utility of chimeric antigen receptor (CAR) T-cell therapies, which yield responses for a minority of patients with hematological malignancies, through innovative CAR design and T-cell engineering, as highlighted in two recent studies. Goodman et al. use a clinically relevant B-cell maturation antigen (BCMA)–specific CAR to show proof-of-principle that a multiplexed approach they call “CAR Pooling” can identify new CAR designs with enhanced activity in a xenotransplant model of disease. In the solid tumor setting, Jung et al. find that activity can be enhanced by knocking out the genes encoding B lymphocyte–induced maturation protein 1 (BLIMP1) and nuclear receptor subfamily 4 group A member 3 (NR4A3) in prostate-specific membrane antigen (PSMA)–specific CAR T cells, countering exhaustion and improving antitumor immunity in a model of prostate cancer.Goodman DB, …, Roybal KT. Sci Trans Med 2022 November 9;14. DOI:10.1126/scitranslmed.abm1463.Jung IY, …, Fraietta JA. Sci Trans Med 2022 November 9;14. DOI: 10.1126/scitranslmed.abn7336.Neutrophils are phenotypically and functionally heterogenous (from Ed Uthman via Wikimedia Commons)Understanding of how the heterogeneity of neutrophils underpins their pro- and antitumorigenic functions is emerging. Through comprehensive analysis of samples from 124 patients with liver cancer and mouse models of the disease, Xue et al. report a detailed landscape of neutrophil phenotypic heterogeneity in liver cancer. Neutrophils are particularly enriched and associated with worse prognosis in liver cancers characterized as having an immune-suppressive myeloid tumor microenvironment. Among the functional analyses performed, CCL4+ and PD-L1+ neutrophil subsets are shown to be protumorigenic, recruiting macrophages and suppressing T-cell cytotoxicity, respectively, suggesting these neutrophil subsets as potential targets for immunotherapy.Xue R, …, Zhang N. Nature 2022 November 9;612:141–47.HEV differentiation can be induced by immunotherapy (from Art Anderson via Wikimedia Commons)The mechanisms underlying changes in blood vessel architecture that are associated with improved T-cell infiltration into solid tumors following immunotherapy treatment are poorly understood. Hua et al. show that immunotherapy in tumor-bearing mice causes tumor endothelial cells to take on phenotypes similar to inflamed high-endothelial venules (HEV), structures characteristic of lymph nodes and tertiary lymphoid structures that facilitate T-cell migration and infiltration. Differentiation into HEVs and increased T-cell infiltration depends on continuous immunotherapy treatment and tumor-infiltrating CD8+ T-cell and NK-cell signaling in a positive-feedback cycle, with HEV niches promoting cytotoxicity of PD1+TCF1+ T cells in the tumor. These findings reveal novel regulatory mechanisms of tumor microenvironment components to support an immunotherapy response.Hua Y, …, Bergers G. Cancer Cell 2022 December 12;40:1600-18.E10.Sensory neurons induce exhaustion in tumor-infiltrating T cells (from Isabella Gavazzi via Wellcome Collection)The interactions between neurons and immune cells in a tumor are not fully understood. Balood et al. show in mouse models of melanoma that tumor cells potentiate nociceptor (pain sensory) neurons via secretory leukocyte protease inhibitor (SLPI) secretion, subsequently driving secretion of neuron-derived calcitonin gene-related peptide (CGRP). CGRP in the tumor microenvironment promotes exhaustion of tumor-reactive infiltrating CD8+ T cells, which can be reduced by depletion of nociceptor neurons, genetic knockout of the CGRP receptor Ramp1, or administration of a selective RAMP1 antagonist. These findings highlight a potentially targetable mechanism of immune evasion in solid tumors at the intersection of the peripheral nervous and immune systems.Balood M, …, Talbot S. Nature 2022 November 2;611:405–12.Intravenous delivery of cancer vaccine improves antitumor responses (from Nic McPhee via Flickr)Vaccines that prime a patient's immune system against cancer neoantigens have so far not demonstrated wide success. By leveraging a neoantigen-delivering nanoparticle vaccine to treat tumor-bearing mice, Baharom et al. find that intravenous (IV) delivery of a booster dose improves T cell–dependent antitumor responses compared to a subcutaneous dose. IV administration enhances delivery to the tumor and increases immune cells in the tumor microenvironment and draining lymph nodes. Response to IV vaccine, which is shown to be independent of the neoantigen delivery, is mediated by IFNα and associated with a reduction in intratumoral regulatory-like CHIL3+ monocytes, suggesting biomarkers and mechanistic pathways for this promising cancer vaccine strategy.Baharom F, …, Seder RA. Cell 2022 November 10;185:4317-32.E15.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
bobo完成签到,获得积分10
8秒前
轻嚣完成签到 ,获得积分10
13秒前
欢喜的如凡完成签到 ,获得积分10
13秒前
000001完成签到,获得积分10
16秒前
16秒前
lyra1111完成签到,获得积分10
17秒前
18秒前
爱我不上火完成签到 ,获得积分10
18秒前
JAYEN完成签到 ,获得积分10
18秒前
Lxx完成签到 ,获得积分10
19秒前
21秒前
简爱完成签到 ,获得积分10
21秒前
LEO2025完成签到 ,获得积分10
22秒前
tszjw168发布了新的文献求助10
22秒前
大方的仙人掌完成签到,获得积分10
22秒前
L050完成签到 ,获得积分10
25秒前
Charlie完成签到 ,获得积分10
25秒前
幸福妙柏完成签到 ,获得积分10
26秒前
宁静的夏天的应助被学不可以已采纳,获得500
29秒前
Chaowei_L完成签到,获得积分10
30秒前
海布里的风完成签到 ,获得积分10
33秒前
王大发完成签到,获得积分10
33秒前
沉默的元枫完成签到,获得积分10
36秒前
tt完成签到,获得积分10
36秒前
乐观的自行车完成签到 ,获得积分10
37秒前
Hansky完成签到,获得积分10
38秒前
乖咪甜球球完成签到 ,获得积分10
41秒前
季末默相依完成签到,获得积分10
42秒前
44秒前
yiyi完成签到 ,获得积分10
44秒前
活力的鹰完成签到 ,获得积分10
44秒前
sea完成签到 ,获得积分10
46秒前
wzk完成签到,获得积分10
48秒前
linpeng发布了新的文献求助10
49秒前
LaixS完成签到,获得积分0
50秒前
要笑cc完成签到,获得积分0
52秒前
顺心妙之完成签到 ,获得积分10
52秒前
dktrrrr完成签到,获得积分10
53秒前
宣宣宣0733完成签到,获得积分0
54秒前
胡质斌完成签到,获得积分0
56秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180084
求助须知:如何正确求助?哪些是违规求助? 9570224
关于积分的说明 21808758
捐赠科研通 7776098
什么是DOI,文献DOI怎么找? 3433261
关于科研通互助平台的介绍 2557454
邀请新用户注册赠送积分活动 2479012